Viewing Study NCT06587867


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-25 @ 2:36 AM
Study NCT ID: NCT06587867
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-08-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Seronegative Myasthenia Gravis - Efgartigimod IV
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module